25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Table of Contents As filed with the Securities and Exchange Commission on May 6, 2022...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:September 28,
Table of Contents Filed pursuant to Rule 424(b)(3) Registration Number 333-259463...
Table of Contents As filed with the Securities and Exchange Commission on September 10, 2021...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
false 0001623613 0001623613 2020-11-16 2020-11-16 UNITED STATES SECURITIES AND EXCHANGE...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
0001623613FALSE2020Q312/31P3Y00016236132020-01-012020-09-30xbrli:shares00016236132020-10-31iso4217:USDxbrli:...
false000162361300016236132020-08-062020-08-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets...
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan...
Pfizer Announces Record Date for the Proposed Transaction Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S...
Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone®...
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn The...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約